Nika BioTechnology, Inc. (NIKA)

is a public company incorporated in Nevada that has its shares traded on OTC Markets.

Our Mission

Our mission is to improve the quality of life for those suffering from AIDS, Cancer, Hepatitis B and C, Diabetes, and other viral based diseases. NIKA strives to be first to market to implement new and revolutionary treatments, which are not only effective, but are also harmless and lack toxicity. NIKA is leveraging twenty-five years of research and development in order to offer a technology that does not have an analogy on the market. Our clinical trial results define that our drugs have an important place in the treatment of AIDS and will provide the opportunity for millions of people suffering from this disease to have access to a better treatment, so that they may have a fulfilling life. The goal of NIKA is to not only chase corporate profits, but to also improve the quality of life of the population by providing better and easier access to life-saving medicinal drugs and useful dietary supplements.